Research

Energy balance

A 3-month intervention combining alternate day fasting (600 kcal on fast days) and moderate-intensity aerobic exercise significantly reduces intrahepatic triglyceride content and associated cardiometabolic risk in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).

For patients with fatty liver disease, a 3-month program of Alternate Day Fasting (eating 600 calories on fast days, normal on others) combined with 5 weekly sessions of moderate exercise (like brisk walking or cycling) significantly reduces liver fat. This approach is a validated, mainstay therapy that works by creating a caloric deficit and improving metabolic markers, even without drastic daily calorie counting.

GoodSupportsHIGH confidence
The trial demonstrated a significant reduction in IHTG among participants randomized to ADF (either alone or in combination with exercise)... Changes in this proteomic signature were associated with changes in intrahepatic triglyceride content over the intervention period (beta=0.12, P<0.001).
Bassim El‐Sabawi et al. · Journal of the American Heart Association · 2025

Why this rating

Randomized clinical trial with a relatively small sample size (N=67) but robust longitudinal proteomic and imaging data, validated against a large community cohort (FHS).

Source

Circulating Proteomics Identifies a Dynamic Profile of Hepatic Steatosis During Metabolic Intervention

Bassim El‐Sabawi et al. · Journal of the American Heart Association · 2025

DOI 10.1161/jaha.124.037100

rct · n=67Cited 2×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →